A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Tumor, immune and neural cells are involved in cancer cachexia
Tumor, immune and neural cells are involved in cancer cachexia
Achondroplasia phase III succeeds for Bridgebio
Achondroplasia phase III succeeds for Bridgebio
Yuhan patents new TREM2 agonists
Yuhan patents new TREM2 agonists
Other news to note for Feb. 12, 2026
Other news to note for Feb. 12, 2026
Financings for Feb. 11, 2026
Financings for Feb. 11, 2026
In the clinic for Feb. 11, 2026
In the clinic for Feb. 11, 2026
Other news to note for Feb. 11, 2026
Other news to note for Feb. 11, 2026
Madrigal adds siRNA approach to MASH pipeline in $4.4B Ribo deal
Madrigal adds siRNA approach to MASH pipeline in $4.4B Ribo deal
NIH ends Xarelto arm of stroke trial due to safety, futility
NIH ends Xarelto arm of stroke trial due to safety, futility
Targeting cholesterol deposition could treat lymphedema
Targeting cholesterol deposition could treat lymphedema
Moderna dips on flu vaccine RTF letter
Moderna dips on flu vaccine RTF letter
Kunshan Xinyunda Biotechnology synthesizes new ADCs
Kunshan Xinyunda Biotechnology synthesizes new ADCs
Aquinnah Pharmaceuticals patents MAPT aggregation inhibitors
Aquinnah Pharmaceuticals patents MAPT aggregation inhibitors
Tempest Therapeutics outlines plans for acquired CAR T assets
Tempest Therapeutics outlines plans for acquired CAR T assets
SUDO-550 demonstrates robust efficacy in MS models
SUDO-550 demonstrates robust efficacy in MS models
Precision Biosciences’ PBGENE-DMD cleared to enter clinic
Precision Biosciences’ PBGENE-DMD cleared to enter clinic
Brazilian scientists identify new HDAC6 inhibitors
Brazilian scientists identify new HDAC6 inhibitors
Financings for Feb. 10, 2026
Financings for Feb. 10, 2026
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page